340 related articles for article (PubMed ID: 29681199)
1. Pregnancy after periviable birth: making the case for innovative delivery of interpregnancy care.
Vani K; Facco FL; Himes KP
J Matern Fetal Neonatal Med; 2019 Nov; 32(21):3577-3580. PubMed ID: 29681199
[No Abstract] [Full Text] [Related]
2. Interpregnancy Interval and Childbirth Outcomes in California, 2007-2009.
Cofer FG; Fridman M; Lawton E; Korst LM; Nicholas L; Gregory KD
Matern Child Health J; 2016 Nov; 20(Suppl 1):43-51. PubMed ID: 27565663
[TBL] [Abstract][Full Text] [Related]
3. Interpregnancy interval after live birth or pregnancy termination and estimated risk of preterm birth: a retrospective cohort study.
Shachar BZ; Mayo JA; Lyell DJ; Baer RJ; Jeliffe-Pawlowski LL; Stevenson DK; Shaw GM
BJOG; 2016 Nov; 123(12):2009-2017. PubMed ID: 27405702
[TBL] [Abstract][Full Text] [Related]
4. Short interpregnancy interval increases the risk of preterm premature rupture of membranes and early delivery.
Shree R; Caughey AB; Chandrasekaran S
J Matern Fetal Neonatal Med; 2018 Nov; 31(22):3014-3020. PubMed ID: 28764570
[TBL] [Abstract][Full Text] [Related]
5. Racial and ethnic disparities in use of 17-alpha hydroxyprogesterone caproate for prevention of preterm birth.
Yee LM; Liu LY; Sakowicz A; Bolden JR; Miller ES
Am J Obstet Gynecol; 2016 Mar; 214(3):374.e1-6. PubMed ID: 26829989
[TBL] [Abstract][Full Text] [Related]
6. 17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial.
Winer N; Bretelle F; Senat MV; Bohec C; Deruelle P; Perrotin F; Connan L; Vayssière C; Langer B; Capelle M; Azimi S; Porcher R; Rozenberg P;
Am J Obstet Gynecol; 2015 Apr; 212(4):485.e1-485.e10. PubMed ID: 25448515
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated with Utilization of 17-Hydroxyprogesterone Caproate for the Prevention of Recurrent Preterm Birth.
DeNoble AE; Wynn CE; Weaver KE; Wheeler SM; Swamy GK
Am J Perinatol; 2020 Feb; 37(3):264-270. PubMed ID: 30708392
[TBL] [Abstract][Full Text] [Related]
8. Disparities in 17-Hydroxyprogesterone Caproate Offer and Uptake in Pregnancies at a Risk of Preterm Birth.
Berhie SH; Riley LE; Bryant AS
Am J Perinatol; 2019 Aug; 36(10):1066-1071. PubMed ID: 30508869
[TBL] [Abstract][Full Text] [Related]
9. Short interpregnancy interval and adverse birth outcomes in women of advanced age: a population-based study.
Ihongbe TO; Wallenborn JT; Rozario S; Masho SW
Ann Epidemiol; 2018 Sep; 28(9):605-611. PubMed ID: 30006251
[TBL] [Abstract][Full Text] [Related]
10. Relation of body mass index to frequency of recurrent preterm birth in women treated with 17-alpha hydroxyprogesterone caproate.
Co AL; Walker HC; Hade EM; Iams JD
Am J Obstet Gynecol; 2015 Aug; 213(2):233.e1-5. PubMed ID: 25912300
[TBL] [Abstract][Full Text] [Related]
11. Effect of Interpregnancy Interval on Adverse Perinatal Outcomes in Southern China: A Retrospective Cohort Study, 2000-2015.
Zhang L; Shen S; He J; Chan F; Lu J; Li W; Wang P; Lam KBH; Mol BWJ; Yeung SLA; Xia H; Schooling CM; Qiu X
Paediatr Perinat Epidemiol; 2018 Mar; 32(2):131-140. PubMed ID: 29293278
[TBL] [Abstract][Full Text] [Related]
12. Effect of interpregnancy interval on adverse pregnancy outcomes in northern Tanzania: a registry-based retrospective cohort study.
Mahande MJ; Obure J
BMC Pregnancy Childbirth; 2016 Jun; 16(1):140. PubMed ID: 27268015
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with short interpregnancy interval among women treated with in vitro fertilization.
Amrane S; Brown MB; Lobo RA; Luke B
J Assist Reprod Genet; 2018 Sep; 35(9):1595-1602. PubMed ID: 30030711
[TBL] [Abstract][Full Text] [Related]
14. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
Manuck TA; Esplin MS; Biggio J; Bukowski R; Parry S; Zhang H; Huang H; Varner MW; Andrews W; Saade G; Sadovsky Y; Reddy UM; Ilekis J;
Am J Obstet Gynecol; 2016 Mar; 214(3):376.e1-8. PubMed ID: 26692181
[TBL] [Abstract][Full Text] [Related]
15. Relationship between interpregnancy interval and cervical length in high-risk women.
Subramaniam A; Wetta LL; Owen J
J Matern Fetal Neonatal Med; 2016; 29(8):1205-8. PubMed ID: 25983138
[TBL] [Abstract][Full Text] [Related]
16. Patient characteristics associated with 17-alpha hydroxyprogesterone caproate use among a high-risk cohort.
Turitz AL; Bastek JA; Purisch SE; Elovitz MA; Levine LD
Am J Obstet Gynecol; 2016 Apr; 214(4):536.e1-536.e5. PubMed ID: 26519784
[TBL] [Abstract][Full Text] [Related]
17. 17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: A retrospective cohort study.
Stringer EM; Vladutiu CJ; Manuck T; Verbiest S; Ollendorff A; Stringer JS; Menard MK
Am J Obstet Gynecol; 2016 Jul; 215(1):105.e1-105.e12. PubMed ID: 26829508
[TBL] [Abstract][Full Text] [Related]
18. [Effects of interpregnancy interval on pregnancy outcomes of subsequent pregnancy: a multicenter retrospective study].
Juan J; Yang HX; Wei YM; Song G; Su RN; Chen X; Yang QH; Yan JY; Xiao M; Li Y; Cui SH; Hu YL; Zhao XL; Fan SR; Feng L; Zhang MH; Ma YY; You ZS; Meng HX; Liu HW; Zhu Y; Wu CF; Cai Y; Hu KJ; Ding HJ
Zhonghua Fu Chan Ke Za Zhi; 2021 Mar; 56(3):161-170. PubMed ID: 33874710
[No Abstract] [Full Text] [Related]
19. Association of Expanded Prenatal Care Coverage for Immigrant Women With Postpartum Contraception and Short Interpregnancy Interval Births.
Rodriguez MI; Kaufman M; Lindner S; Caughey AB; DeFede AL; McConnell KJ
JAMA Netw Open; 2021 Aug; 4(8):e2118912. PubMed ID: 34338791
[TBL] [Abstract][Full Text] [Related]
20. Effect of Modifiable Risk Factors on Preterm Birth: A Population Based-Cohort.
Lengyel CS; Ehrlich S; Iams JD; Muglia LJ; DeFranco EA
Matern Child Health J; 2017 Apr; 21(4):777-785. PubMed ID: 27485494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
